215 related articles for article (PubMed ID: 6154662)
21. Natural killer inhibitory substance produced by the peritoneal cells of patients with ovarian cancer.
Lichtenstein AK; Berek J; Zighelboim J
J Natl Cancer Inst; 1985 Feb; 74(2):349-55. PubMed ID: 3856049
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
[TBL] [Abstract][Full Text] [Related]
23. Natural killer cell activity and autologous tumor killing activity in cancer patients: overlapping involvement of effector cells as determined in two-target conjugate cytotoxicity assay.
Uchida A; Yanagawa E
J Natl Cancer Inst; 1984 Nov; 73(5):1093-100. PubMed ID: 6593485
[TBL] [Abstract][Full Text] [Related]
24. Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions.
Uchida A; Micksche M
Int J Cancer; 1983 Jul; 32(1):37-44. PubMed ID: 6862692
[TBL] [Abstract][Full Text] [Related]
25. Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence, and cytolysis.
Helfand SL; Werkmeister J; Roder JC
J Exp Med; 1982 Aug; 156(2):492-505. PubMed ID: 6178787
[TBL] [Abstract][Full Text] [Related]
26. Antagonistic effects of interferons on the cytotoxicity mediated by natural killer cells.
Trinchieri G; Santoli D; Granato D; Perussia B
Fed Proc; 1981 Oct; 40(12):2705-10. PubMed ID: 6169557
[TBL] [Abstract][Full Text] [Related]
27. Natural killer cell activity in reticulum-cell sarcomas of SJL/J mice. II. Analysis of RCS-associated NK activity.
Fitzgerald KL; Ponzio NM
Int J Cancer; 1981 Nov; 28(5):627-34. PubMed ID: 6171532
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxicity on tumor cells of peripheral blood monocytes and tumor-associated macrophages in patients with ascites ovarian tumors.
Mantovani A; Polentarutti N; Peri G; Shavit ZB; Vecchi A; Bolis G; Mangioni C
J Natl Cancer Inst; 1980 Jun; 64(6):1307-15. PubMed ID: 6246299
[TBL] [Abstract][Full Text] [Related]
29. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
Uchida A; Vánky F; Klein E
J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
[TBL] [Abstract][Full Text] [Related]
30. Human natural killer-like activity against mouse spleen cells.
Yamamoto JK; Blalock JE; Johnson HM
Eur J Immunol; 1982 Mar; 12(3):222-7. PubMed ID: 7047174
[TBL] [Abstract][Full Text] [Related]
31. Suppression of natural killer cell activity by adherent effusion cells of cancer patients. Suppression of motility, binding capacity and lethal hit of NK cells.
Uchida A; Colot M; Micksche M
Br J Cancer; 1984 Jan; 49(1):17-23. PubMed ID: 6691897
[TBL] [Abstract][Full Text] [Related]
32. Ex vivo expansion of CD56+ NK and NKT-like lymphocytes from peripheral blood mononuclear cells of patients with ovarian neoplasia.
Alves PCM; De Angelo Andrade LAL; Petta CA; Lorand-Metze I; Derchain SF; Guimarães F
Scand J Immunol; 2011 Sep; 74(3):244-252. PubMed ID: 21595734
[TBL] [Abstract][Full Text] [Related]
33. Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells.
Carlsten M; Norell H; Bryceson YT; Poschke I; Schedvins K; Ljunggren HG; Kiessling R; Malmberg KJ
J Immunol; 2009 Oct; 183(8):4921-30. PubMed ID: 19801517
[TBL] [Abstract][Full Text] [Related]
34. Discrepancy between phenotypic and functional features of natural killer T-lymphocytes in B-cell chronic lymphocytic leukaemia.
Foa R; Lauria F; Lusso P; Giubellino MC; Fierro MT; Ferrando ML; Raspadori D; Matera L
Br J Haematol; 1984 Nov; 58(3):509-16. PubMed ID: 6333890
[TBL] [Abstract][Full Text] [Related]
35. Interferon production and tumor cell killing by human lymphocytes stimulated in mixed-lymphocyte culture.
Peterman GM; Stanton GJ; Altman LC; Klimpel GR
Cell Immunol; 1984 Apr; 85(1):114-24. PubMed ID: 6201284
[TBL] [Abstract][Full Text] [Related]
36. Purification and target cell range of in vivo elicited blast natural killer cells.
Biron CA; Pedersen KF; Welsh RM
J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
[TBL] [Abstract][Full Text] [Related]
37. Natural killing (NK) of cytomegalovirus (CMV)-infected fibroblasts: a comparison between two strains of CMV, uninfected fibroblasts, and K562 cells.
Waner JL; Nierenberg JA
J Med Virol; 1985 Jul; 16(3):233-44. PubMed ID: 2993494
[TBL] [Abstract][Full Text] [Related]
38. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
[TBL] [Abstract][Full Text] [Related]
39. Natural killer cell cytotoxic potential of patients with ovarian carcinoma and its modulation with virus-modified tumor cell extract.
Lotzová E; Savary CA; Freedman RS; Bowen JM
Cancer Immunol Immunother; 1984; 17(2):124-9. PubMed ID: 6205745
[TBL] [Abstract][Full Text] [Related]
40. Augmentation of human natural killer cell activity by interferon: conditions required for boosting and characteristics of the effector cells.
Ortaldo JR; Lang NP; Timonen T; Herberman RB
J Interferon Res; 1981 Feb; 1(2):253-62. PubMed ID: 6180056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]